Skip to Main Content
CKG
Home
Home
Home
TKG
Paper Details
Breadcrumb
Paper Details
Paper Title
Large-scale transcriptomic analysis reveals that pridopidine reverses aberrant gene expression and activates neuroprotective pathways in the YAC128 HD mouse.
PubMed
Paper Journal Title
Mol Neurodegener
Paper Citation Count
24
Paper Publication Year
2018
Bio Mention
BDNF, D1R, GR, HD, Huntington Disease, NE-100, Pridopidine, RNAseq, YAC128, alternative exon, autosomal dominant neurodegenerative disorder, brain-derived neurotrophic factor, cAMP, calcium, dopamine, dopamine D1 receptor, genes, glucocorticoid receptor, human, human mHtt gene, mHtt, mice, mouse, mutant huntingtin protein, neuronal cultures, patients, pridopidine, rat, sigma-1 receptor, transcript
Mesh Descriptor
Go
Actions
Author Name
Affiliation
Rebecca Kusko
Immuneering Corporation
Renan Escalante-Chong
Immuneering Corporation
Liang Juin Tan
Michael R Hayden
Teva Pharmaceutical Industries Ltd
Michael R Hayden
Michael R Hayden
Child and Family Research Institute, University of British Columbia
Michael R Hayden
Yong Loo Lin School of Medicine, National University of Singapore
1 - 7
Column Actions
Search
Datasets